CareEvolution Webinar Highlights Healthcare Data Management Evolution
Health tech experts explained the nuances of healthcare data management and ways in which patient data can be cleaned, converted, standardized and harmonized across systems
Health tech experts explained the nuances of healthcare data management and ways in which patient data can be cleaned, converted, standardized and harmonized across systems
It is critical for policymakers to work with nephology RNs to increase federal resources that will enable us to address burnout, decrease turnover rates, and build and support a stronger healthcare workforce nationwide.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
By leveraging its large membership, Medicare could by embracing value-based contracting significantly influence the pharmaceutical market, pitting competing drugs against each other, or encouraging pharmaceutical makers to figure out ways to deliver drugs more cheaply.
Value-based care has provided a platform and a mechanism, where for the first time, health plans, providers and employer groups are sitting around the table with their sleeves rolled up, ready to collaborate and partner as opposed to sitting across the table with their arms crossed and their heels dug in.
At the upcoming INVEST Digital Health conference in Dallas set for September 28, in collaboration with Health Wildcatters, a panel discussion on the future of pharmacy benefit managers will be part of the larger conversation on employee benefits. AJ Loiacono, CapitalRx CEO, shared his perspective on the topic.
The decision about whether to allow the procedure now falls to individual state governments, and only 16, plus the District of Columbia, have passed laws to preserve the option, while two others have state constitutional protections that have been cited by state courts as protections for abortion.
Pharma companies often take the blame for high prescription costs. But a new, industry-sponsored survey shifts attention to insurance industry practices.
The Biden administration aims to have all Medicare beneficiaries enrolled in alternative payment models by 2030. Aneesh Chopra, the federal government's first-ever chief technology officer and currently president of CareJourney, says this push for alternative payment models will lead not only to a reduction in unnecessary expenditures but also higher preventive service utilization and more primary care visits.
Register to view a webinar, sponsored by Surescripts, highlighting progress made on interoperability and what's needed to improve and expand it.
Large swaths of the country had no test-to-treat pharmacies or health centers listed as of April 14. And the website of the largest participant, CVS, has significant technical issues that make booking an appointment difficult.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
A recent webinar sponsored by Formlabs underscored the value of 3D printing from a clinical perspective and offered insight on how commercial and regulatory players are thinking about this space.
Here is a selection of recent executive hires and departures across healthcare and life sciences.
A webinar, sponsored by Surescripts on April 28, will include: Surescripts CEO Tom Skelton, Epic CEO Judy Faulkner, Healthcare Leadership Council President Mary Grealy, and UC San Francisco Assistant Professor of Medicine A. Jay Holmgren. Register today!
When the healthcare industry talks about data, the conversation usually focuses on interoperability and data standards. While these are certainly important, the most effective way to connect the dots and gain a complete view of a patient is through data normalization.
Six years in, the subtext of the scheduled reimbursements increase for 2022 is that CCM has proven to be an essential part of the care continuum, particularly in the wake of the Covid-19 pandemic, and has real value for patients, providers, and payers.